OverT Bio
PrivateLast Round
Grant
Nov 22, 2024
Total Funding Raised
$16.12M
Momentum Score
25 /100
Company Overview
OverT Bio is a biotechnology company specializing in innovative cell therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OverT Bio Comps
Public and private peers based on sector, stage, and business model.
OverT Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 22, 2024 | ||||
| Seed | May 6, 2024 |
Key People
Founding team and executive leadership
OverT Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fusion Fund | Seed |
| Gaingels | Seed |
| ARTIS Ventures | Seed |
| Hawktail Management | Seed |
| Alexandria Venture Investments | Seed |
| OMX Ventures | Seed |
| Cancer Research Institute | Seed |
OverT Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OverT Bio's valuation, stock price, and market status.
